Technology And Equipment Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Metoprolol and Hydrochlorothiazide (C07bb22) as Part of a House Model.

Open House Drug Discount Agreements Glatiramer Acetate, in Pre-Filled Pen Dosage Form, Atc L03ax13

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Valproic Acid (N03ag01) as Part of a So-Called Open House Model.

Drugs Containing the Active Ingredient Cinacalcet (Atc: H05bx01)

Drugs Containing the Active Substance Valproic Acid (Atc: N03ag01)

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Biperiden (N04aa02) as Part of a So-Called Open House Model.

Open House Drug Discount Contractsibuprofen, Prescription, in Immediate-Release Dosage Form with a Potency of 800 Mg, Atc M01ae01

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Fulvestrant (L02ba03) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Tapentadol (N02ax06) as Part of a So-Called Open House Model.